BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.27 -0.03 (-2.31%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioNexus Gene Lab (BGLC) EBITDA Margin (2018 - 2026)

Updated

BioNexus Gene Lab (BGLC) posted EBITDA Margin of -333.96% for Q2 2026, down 308.15 percentage points from -25.82% a year earlier but up 1908.39 percentage points from the prior quarter.

Analysis

BioNexus Gene Lab (BGLC) EBITDA Margin (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at BioNexus Gene Lab was -78.18%, down 48.18 percentage points year-over-year; for FY2025, it came in at -38.43%, down 22.98 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -50.41 percentage points (FY2020 to FY2025).
  • In prior years, BioNexus Gene Lab's EBITDA Margin was -15.45% in FY2024 (+10.24 pp), -25.69% in FY2023 (-23.86 pp), -1.83% in FY2022 (-10.41 pp) and 8.58% in FY2021 (-3.40 pp).
  • Quarterly EBITDA Margin has run from a low of -2242.35% in Q1 2026 to a high of 14.69% in Q2 2024 over five years.
  • On a year-over-year basis, EBITDA Margin has declined in each of the last three quarters, with an average year-over-year change of -342.25 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2024, with a gain of 47.30 percentage points; the weakest was Q1 2026, with a drop of 2214.66 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -2242.35% (Q1 2026), -207.63% (Q4 2025) and -26.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 W.W. Grainger 59.11 Bn 57.09 Bn 1.98 Bn 17.39%
2 Fastenal 57.94 Bn 56.86 Bn 1.06 Bn 22.93%
3 Ferguson Enterprises 44.13 Bn 41.35 Bn 2.32 Bn 9.49%
4 Sunbelt Rentals Holdings 30.69 Bn 30.57 Bn 1.25 Bn 40.96%
5 Reliance 20.00 Bn 19.04 Bn 1.30 Bn 11.04%
6 Wesco International 17.78 Bn 15.09 Bn 1.46 Bn 6.68%
7 Applied Industrial Technologies 12.42 Bn 12.29 Bn 411.22 Mn 12.98%
8 Watsco 11.14 Bn 9.30 Bn 578.93 Mn 11.84%
9 Avantor 10.34 Bn 9.14 Bn 537.00 Mn 13.44%
10 BioNexus Gene Lab 2.41 Mn -4.96 Mn 12,982.00 -333.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -333.96%
Mar 31, 2026 -2,242.35%
Dec 31, 2025 -207.63%
Sep 30, 2025 -26.48%
Jun 30, 2025 -25.82%
Mar 31, 2025 -27.69%
Dec 31, 2024 -15.32%
Sep 30, 2024 -49.55%
Jun 30, 2024 14.69%
Mar 31, 2024 -2.47%
Dec 31, 2023 12.22%
Sep 30, 2023 -96.85%
Jun 30, 2023 -11.11%
Mar 31, 2023 -1.25%
Dec 31, 2022 -3.45%
Sep 30, 2022 -1.69%
Jun 30, 2022 -4.64%
Mar 31, 2022 1.88%
Dec 31, 2021 6.90%
Sep 30, 2021 11.05%
API Access

BioNexus Gene Lab EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BGLC&period=max&api_key=YOUR_API_KEY